Aytu BioScience continues to deliver positive news to its shareholders, and the stock has responded by rising more than 120% year to date. Four products are contributing to the revenue mix with Natesto, ZolpiMist, Tuzistra XR, and MiOXSYS each targeting separate billion-dollar markets. This short video explains what AYTU is doing to extend their reach […]
